NEW YORK STATE COMMON RETIREMENT FUND - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$467
-55.5%
22,688
+1.7%
0.00%0.0%
Q2 2023$1,049
-11.2%
22,309
-20.8%
0.00%
-50.0%
Q1 2023$1,181
-20.7%
28,151
-27.9%
0.00%0.0%
Q4 2022$1,490
-99.9%
39,058
+0.0%
0.00%0.0%
Q3 2022$1,529,000
+29.7%
39,051
+7.0%
0.00%0.0%
Q2 2022$1,179,000
-51.2%
36,508
-50.0%
0.00%
-33.3%
Q1 2022$2,415,000
-17.8%
72,946
+5.7%
0.00%0.0%
Q4 2021$2,937,000
-7.1%
69,033
-3.2%
0.00%0.0%
Q3 2021$3,161,000
-54.4%
71,347
-41.5%
0.00%
-57.1%
Q2 2021$6,929,000
-26.5%
121,965
-3.2%
0.01%
-30.0%
Q1 2021$9,426,000
-20.7%
125,936
-8.3%
0.01%
-23.1%
Q4 2020$11,881,000
+49.9%
137,336
+5.9%
0.01%
+30.0%
Q3 2020$7,925,000
+60.8%
129,669
+9.4%
0.01%
+66.7%
Q2 2020$4,928,000
-11.0%
118,526
-38.5%
0.01%
-25.0%
Q1 2020$5,539,000
-64.3%
192,879
-10.4%
0.01%
-55.6%
Q4 2019$15,536,000
-58.6%
215,212
-19.6%
0.02%
-62.5%
Q3 2019$37,560,000
-24.8%
267,731
-1.9%
0.05%
-23.8%
Q2 2019$49,953,000
+11.4%
272,833
-3.2%
0.06%
+8.6%
Q1 2019$44,838,000
+71.2%
281,913
+3.1%
0.06%
+52.6%
Q4 2018$26,190,000
-30.5%
273,407
+2.5%
0.04%
-15.6%
Q3 2018$37,695,000
-10.3%
266,868
-0.6%
0.04%
-13.5%
Q2 2018$42,039,000
+49.4%
268,568
+53.8%
0.05%
+48.6%
Q1 2018$28,131,000
+6.5%
174,650
+9.0%
0.04%
+9.4%
Q4 2017$26,402,000
+183.3%
160,295
+7.2%
0.03%
+166.7%
Q3 2017$9,318,000
+180.0%
149,564
+258.0%
0.01%
+200.0%
Q2 2017$3,328,000
+22.3%
41,782
+9.1%
0.00%0.0%
Q1 2017$2,721,000
+30.0%
38,283
-6.6%
0.00%
+33.3%
Q4 2016$2,093,000
+42.6%
40,988
+28.5%
0.00%
+50.0%
Q3 2016$1,468,000
+195.4%
31,888
+93.3%
0.00%
+100.0%
Q2 2016$497,000
-23.5%
16,500
-18.6%
0.00%0.0%
Q1 2016$650,000
-36.3%
20,263
+15.8%
0.00%
-50.0%
Q4 2015$1,020,000
+37.7%
17,5010.0%0.00%
+100.0%
Q3 2015$741,000
-30.4%
17,501
+20.1%
0.00%
-50.0%
Q2 2015$1,064,000
+511.5%
14,577
+321.1%
0.00%
Q1 2015$174,0003,4620.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders